Home
/
Vanda Pharmaceuticals Inc.
/
Financials
/
Quarterly
Vanda Pharmaceuticals Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Vanda Pharmaceuticals Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$56.26M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$52.59M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$50.04M
May 8, 2025
Q3
2025
Sep 30, 2024
$47.65M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$50.47M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$47.46M
May 8, 2025
Q3
2024
Sep 30, 2023
$38.82M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$46.06M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$62.50M
May 9, 2024
Q3
2023
Sep 30, 2022
$65.32M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$64.39M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$60.19M
May 3, 2023
Q3
2022
Sep 30, 2021
$70.10M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$67.90M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$62.67M
May 6, 2022
Q3
2021
Sep 30, 2020
$60.31M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$62.21M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$58.00M
May 6, 2021
Q3
2020
Sep 30, 2019
$59.49M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$59.06M
Aug 6, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$56.26M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$52.59M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$50.04M
May 8, 2025
Q3
2025
Sep 30, 2024
$47.65M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$50.47M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$47.46M
May 8, 2025
Q3
2024
Sep 30, 2023
$38.82M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$46.06M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$62.50M
May 9, 2024
Q3
2023
Sep 30, 2022
$65.32M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$64.39M
Jul 28, 2023
Q1
2023
Mar 31, 2022
$60.19M
May 3, 2023
Q3
2022
Sep 30, 2021
$70.10M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$67.90M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$62.67M
May 6, 2022
Q3
2021
Sep 30, 2020
$60.31M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$62.21M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$58.00M
May 6, 2021
Q3
2020
Sep 30, 2019
$59.49M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$59.06M
Aug 6, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2013
Sep 30, 2013
$8.71M
Nov 8, 2013
Q2
2013
Jun 30, 2013
$8.32M
Jul 31, 2013
Q1
2013
Mar 31, 2013
$8.07M
May 10, 2013
Q3
2012
Sep 30, 2012
$8.29M
Nov 8, 2012
Q2
2012
Jun 30, 2012
$8.38M
Aug 3, 2012
Q1
2012
Mar 31, 2012
$8.14M
May 9, 2012
Q3
2011
Sep 30, 2011
$7.97M
Nov 7, 2011
Q2
2011
Jun 30, 2011
$7.43M
Aug 5, 2011
Q1
2012
Mar 31, 2011
$7.50M
May 9, 2012
Q3
2011
Sep 30, 2010
$7.25M
Nov 7, 2011
Q2
2011
Jun 30, 2010
$8.29M
Aug 5, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.59M)
Oct 30, 2025
Q3
2025
Jun 30, 2025
($27.21M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($27.21M)
Jul 31, 2025
Q3
2025
Mar 31, 2025
($29.49M)
Oct 30, 2025
Q1
2025
Mar 31, 2025
($29.49M)
May 8, 2025
Q2
2025
Mar 31, 2025
($29.49M)
Jul 31, 2025
Q3
2025
Sep 30, 2024
($5.32M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($4.52M)
Jul 31, 2025
Q3
2025
Jun 30, 2024
($4.52M)
Oct 30, 2025
Q2
2025
Mar 31, 2024
($4.15M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($4.15M)
May 8, 2025
Q3
2025
Mar 31, 2024
($4.15M)
Oct 30, 2025
Q3
2024
Sep 30, 2023
$137.0K
Nov 7, 2024
Q3
2024
Jun 30, 2023
$1.52M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$1.52M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$3.25M
May 9, 2024
Q3
2024
Mar 31, 2023
$3.25M
Nov 7, 2024
Q2
2024
Mar 31, 2023
$3.25M
Aug 1, 2024
Q3
2023
Sep 30, 2022
$3.27M
Nov 9, 2023
Q3
2023
Jun 30, 2022
$2.57M
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($31.28M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($38.50M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($41.03M)
May 8, 2025
Q3
2025
Sep 30, 2024
($11.00M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($10.15M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($9.24M)
May 8, 2025
Q3
2024
Sep 30, 2023
($6.00M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($2.87M)
Aug 1, 2024
Q1
2024
Mar 31, 2023
$2.00M
May 9, 2024
Q3
2023
Sep 30, 2022
$3.91M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$3.46M
Jul 28, 2023
Q1
2023
Mar 31, 2022
($7.67M)
May 3, 2023
Q3
2022
Sep 30, 2021
$10.82M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$12.37M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$10.34M
May 6, 2022
Q3
2021
Sep 30, 2020
$7.74M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$9.17M
Jul 29, 2021
Q1
2021
Mar 31, 2020
($125.0K)
May 6, 2021
Q3
2020
Sep 30, 2019
$10.76M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$9.90M
Aug 6, 2020